Free CCP Federal Regulations and Surveys Questions and Answers 1 — Questions and Answers
Question 1: A state surveyor is reviewing a long-term care facility's medication management system. The surveyor notes that for PRN psychotropic medications, the prescribing physician has documented rationale for extending the orders beyond 14 days. However, the documentation only states 'continue for behaviors.' According to CMS regulations (F-Tag 758), why would this be cited as a deficiency?
- The documentation must specify the duration for the PRN order.
- PRN psychotropic medications cannot be extended beyond 14 days under any circumstances.
- Only the consultant pharmacist can approve extensions for PRN psychotropic medications.
- The documentation lacks a specific, targeted condition and evidence of non-pharmacological interventions. (Correct answer)
Correct answer: The documentation lacks a specific, targeted condition and evidence of non-pharmacological interventions.
CMS regulations require that PRN orders for psychotropic drugs are limited to 14 days unless the practitioner documents a specific rationale for continuation. This rationale must include the specific condition being treated and indicate the duration. A vague reason like 'for behaviors' is insufficient and does not align with the requirement to treat a specific, documented condition, implying a potential use for staff convenience rather than resident need.
Question 2: A consultant pharmacist identifies that a resident's attending physician has not responded to a written recommendation regarding a significant medication irregularity for over two weeks. According to federal regulation §483.45(c) (F-Tag 756), what is the pharmacist's required next step?
- Discontinue the medication immediately based on their clinical judgment.
- Report the irregularity to the facility's Medical Director and Director of Nursing. (Correct answer)
- Wait for the next monthly Medication Regimen Review to address it again.
- Contact the resident's family directly to inform them of the situation.
Correct answer: Report the irregularity to the facility's Medical Director and Director of Nursing.
Federal regulations under §483.45(c), associated with F-Tag 756, explicitly state that the pharmacist must report any irregularities to the attending physician, the facility's medical director, and the director of nursing. If the attending physician does not act upon the report, elevating the concern to the medical director and DON is the required escalation path to ensure resident safety and regulatory compliance.
Question 3: During an annual survey, a surveyor is auditing the facility's compliance with DEA regulations for controlled substances. Which of the following scenarios represents a violation of federal DEA requirements for a Long-Term Care Facility (LTCF)?
- A nurse acting as an agent of the physician faxes a prescription for a Schedule III medication to the pharmacy.
- The pharmacy partially fills a Schedule II prescription, with the remainder to be dispensed within 60 days.
- A nurse takes a verbal order from a physician for an emergency 72-hour supply of a Schedule II medication.
- The facility uses a 'chart order' for a Schedule II medication as a valid prescription to be sent to the dispensing pharmacy. (Correct answer)
Correct answer: The facility uses a 'chart order' for a Schedule II medication as a valid prescription to be sent to the dispensing pharmacy.
The DEA has ruled that a 'chart order' in a resident's medical record is not considered a valid prescription for dispensing purposes by a retail pharmacy for a Schedule II controlled substance. A separate, valid, signed prescription is required. While nurses may act as an agent for transmitting Schedule III-V prescriptions, and specific rules exist for partial fills and emergency supplies of Schedule II drugs, using a chart order as the primary prescription document for dispensing a Schedule II drug is a violation.
Question 4: A long-term care facility is cited under F-Tag 757, 'Unnecessary Drugs.' Which of the following situations would most likely lead to this specific citation, based on recent CMS guidance updates?
- A resident receiving an antipsychotic PRN for more than 14 days without documented rationale for continuation.
- A resident on two different benzodiazepines from the same class without a clear indication for duplicate therapy. (Correct answer)
- Failure to attempt a Gradual Dose Reduction (GDR) for a resident on a long-standing antidepressant.
- Administering a hypnotic for sleep without adequate monitoring for side effects like daytime drowsiness.
Correct answer: A resident on two different benzodiazepines from the same class without a clear indication for duplicate therapy.
Recent CMS updates have streamlined survey guidance. Issues related to psychotropic drugs, such as PRN use, GDRs, and monitoring, are now primarily consolidated under other F-Tags (like F605). F-Tag 757 is now more focused on non-psychotropic 'unnecessary medications.' Duplicate drug therapy, such as using two benzodiazepines concurrently without a clear rationale, is a classic example of an unnecessary medication situation that would be cited under F757.
Question 5: The State Operations Manual (SOM), Appendix PP provides guidance to surveyors for long-term care facilities. What is the primary purpose of this document in the context of a consultant pharmacist's role?
- To provide a fee schedule for Medication Regimen Review services.
- To outline the specific clinical guidelines for treating common geriatric conditions.
- To detail the investigative protocols and interpret the regulations surveyors use to assess facility compliance. (Correct answer)
- To list the required inventory of medications for the facility's emergency drug kit.
Correct answer: To detail the investigative protocols and interpret the regulations surveyors use to assess facility compliance.
The CMS State Operations Manual (SOM), specifically Appendix PP, contains the interpretive guidelines and survey protocols that state surveyors use to determine if a facility is in compliance with federal regulations (Conditions of Participation). For a consultant pharmacist, understanding this document is critical as it explains how their services—such as MRRs, reporting irregularities, and ensuring freedom from unnecessary medications—will be evaluated during a survey.
Question 6: CMS has placed increasing emphasis on the 'independence' of the consultant pharmacist. What is the primary concern that prompted this regulatory focus?
- A concern that pharmacists employed by the facility may be pressured to approve cost-cutting measures that harm residents.
- A desire to have pharmacists report survey deficiencies directly to CMS instead of the facility.
- A potential conflict of interest where a pharmacist affiliated with the dispensing pharmacy might favor that pharmacy's products. (Correct answer)
- A belief that independent pharmacists have more up-to-date clinical knowledge than those affiliated with a single pharmacy.
Correct answer: A potential conflict of interest where a pharmacist affiliated with the dispensing pharmacy might favor that pharmacy's products.
CMS has expressed concern that a consultant pharmacist who is employed by or under contract with the facility's long-term care pharmacy may have a conflict of interest. This arrangement could potentially lead to biased drug regimen reviews that favor the dispensing pharmacy's formulary, preferred drugs, or other financial incentives, rather than being based solely on the resident's best clinical interests.
Free CCP Federal Regulations and Surveys Questions and Answers 1
A state surveyor is reviewing a long-term care facility's medication management system.
The surveyor notes that for PRN psychotropic medications, the prescribing physician has documented rationale for extending the orders beyond 14 days.
However, the documentation only states 'continue for behaviors.' According to CMS regulations (F-Tag 758), why would this be cited as a deficiency?